Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections
暂无分享,去创建一个
[1] M. Repka,et al. Amblyopia Preferred Practice Pattern®. , 2022, Ophthalmology.
[2] Hane Lee,et al. Congenital Stationary Night Blindness: Clinical and Genetic Features , 2022, International journal of molecular sciences.
[3] N. Parry,et al. Retinal gene therapy in RPE-65 gene mediated inherited retinal dystrophy , 2022, Eye.
[4] D. Bosnar,et al. RPE65 c.353G>A, p.(Arg118Lys): A Novel Point Mutation Associated with Retinitis Pigmentosa and Macular Atrophy , 2022, International journal of molecular sciences.
[5] V. Sheffield,et al. Progressive retinal degeneration of rods and cones in a Bardet-Biedl syndrome type 10 mouse model , 2022, Disease models & mechanisms.
[6] J. Ruiz-Ederra,et al. Subretinal Injection Techniques for Retinal Disease: A Review , 2022, Journal of clinical medicine.
[7] E. Zrenner,et al. Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort , 2022, Genes.
[8] P. Melillo,et al. RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study , 2022, Investigative ophthalmology & visual science.
[9] T. Aleman,et al. Comparative Natural History of Visual Function From Patients With Biallelic Variants in BBS1 and BBS10 , 2021, Investigative ophthalmology & visual science.
[10] Chang-Hao Yang,et al. Leber’s Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations , 2021, Genes.
[11] K. Xue,et al. Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina , 2021, Molecular therapy. Methods & clinical development.
[12] S. Woo,et al. Clinical and Genetic Characteristics of Korean Congenital Stationary Night Blindness Patients , 2021, Genes.
[13] I. Buño,et al. Novel biallelic variant in BBS9 causative of Bardet–Biedl syndrome: expanding the spectrum of disease-causing genetic alterations , 2021, BMC medical genomics.
[14] Xiaohong Meng,et al. Ocular Characteristics of Patients With Bardet–Biedl Syndrome Caused by Pathogenic BBS Gene Variation in a Chinese Cohort , 2021, Frontiers in Cell and Developmental Biology.
[15] Z. Tümer,et al. BBS Proteins Affect Ciliogenesis and Are Essential for Hedgehog Signaling, but Not for Formation of iPSC-Derived RPE-65 Expressing RPE-Like Cells , 2021, International journal of molecular sciences.
[16] K. Ahmad,et al. Congenital stationary night blindness: an update and review of the disease spectrum in Saudi Arabia , 2020, Acta ophthalmologica.
[17] S. Tsang,et al. Gene therapy for inherited retinal diseases , 2020, Annals of translational medicine.
[18] T. Aleman,et al. Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Sumit Kumar,et al. Multiple retinal astrocytic hamartomas in siblings with lebers congenital amaurosis: a case series and review of literature , 2020, BMC Ophthalmology.
[20] S. Tsang,et al. Optical coherence tomography in the evaluation of retinitis pigmentosa , 2020, Ophthalmic genetics.
[21] Denise J. Pearson,et al. Treatment Potential for LCA5-Associated Leber Congenital Amaurosis , 2020, Investigative ophthalmology & visual science.
[22] B. Lujan,et al. Retinal gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial , 2020, Nature Medicine.
[23] Yihua Zhu,et al. The effect of human gene therapy for RPE65-associated Leber’s congenital amaurosis on visual function: a systematic review and meta-analysis , 2020, Orphanet Journal of Rare Diseases.
[24] C. Méndez-Vidal,et al. Unmasking Retinitis Pigmentosa complex cases by a whole genome sequencing algorithm based on open-access tools: hidden recessive inheritance and potential oligogenic variants , 2020, Journal of Translational Medicine.
[25] W. Hauswirth,et al. Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] Kathleen A. Marshall,et al. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. , 2019, Ophthalmology.
[27] M. McCall,et al. Presynaptic Expression of LRIT3 Transsynaptically Organizes the Postsynaptic Glutamate Signaling Complex Containing TRPM1 , 2019, Cell reports.
[28] D. Gesellschaft,et al. Stellungnahme von DOG, RG und BVA zur therapeutischen Anwendung von voretigene neparvovec (Luxturna™) in der Augenheilkunde , 2019, Der Ophthalmologe.
[29] P. Mathur,et al. Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina , 2019, Hearing Research.
[30] M. Nakazawa,et al. The findings of optical coherence tomography of retinal degeneration in relation to the morphological and electroretinographic features in RPE65−/− mice , 2019, PloS one.
[31] B. J. Klevering,et al. Non-syndromic retinitis pigmentosa , 2018, Progress in Retinal and Eye Research.
[32] Sieu K. Khuu,et al. Optical treatment of amblyopia: a systematic review and meta‐analysis , 2018, Clinical & experimental optometry.
[33] B. Wilhelm,et al. Humoral Immune Response After Intravitreal But Not After Subretinal AAV8 in Primates and Patients. , 2018, Investigative ophthalmology & visual science.
[34] B. Wilhelm,et al. Superior Retinal Gene Transfer and Biodistribution Profile of Subretinal Versus Intravitreal Delivery of AAV8 in Nonhuman Primates. , 2017, Investigative ophthalmology & visual science.
[35] P. Campochiaro,et al. The mechanism of cone cell death in Retinitis Pigmentosa , 2017, Progress in Retinal and Eye Research.
[36] Kathleen A. Marshall,et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial , 2017, The Lancet.
[37] M. Michaelides,et al. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions , 2017, British Journal of Ophthalmology.
[38] S. Halford,et al. Unravelling the genetics of inherited retinal dystrophies: Past, present and future , 2017, Progress in Retinal and Eye Research.
[39] H. Ahn,et al. Prevalence, Age at Diagnosis, Mortality, and Cause of Death in Retinitis Pigmentosa in Korea-A Nationwide Population-based Study. , 2017, American journal of ophthalmology.
[40] B. Hafler. CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING , 2017, Retina.
[41] T. Hohman,et al. Hereditary Retinal Dystrophy. , 2016, Handbook of experimental pharmacology.
[42] G. Liew,et al. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention , 2016, British Journal of Ophthalmology.
[43] S. Nampoothiri,et al. Bardet–Biedl syndrome: Genetics, molecular pathophysiology, and disease management , 2016, Indian journal of ophthalmology.
[44] Jean Bennett,et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial , 2016, The Lancet.
[45] David J. Wilson,et al. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy. , 2016, Ophthalmology.
[46] Fang Wang,et al. Optical Coherence Tomographic Analysis of Retina in Retinitis Pigmentosa Patients , 2016, Ophthalmic Research.
[47] Rick Tearle,et al. Whole Genome Sequencing Increases Molecular Diagnostic Yield Compared with Current Diagnostic Testing for Inherited Retinal Disease , 2016, Ophthalmology.
[48] V. Sheffield,et al. Mutations in C8ORF37 cause Bardet Biedl syndrome (BBS21). , 2016, Human molecular genetics.
[49] Dongli Yang,et al. N-Acetylcysteine Amide Protects Against Oxidative Stress–Induced Microparticle Release From Human Retinal Pigment Epithelial Cells , 2016, Investigative ophthalmology & visual science.
[50] W. Hauswirth,et al. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial , 2016, Human Genetics.
[51] Rémy Bruggmann,et al. Clinical sequencing: is WGS the better WES? , 2016, Human Genetics.
[52] E. Strettoi,et al. Pharmacological approaches to retinitis pigmentosa: A laboratory perspective , 2015, Progress in Retinal and Eye Research.
[53] E. Simpson,et al. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. , 2015, Human molecular genetics.
[54] G. Holder,et al. Predominantly Cone-System Dysfunction as Rare Form of Retinal Degeneration in Patients With Molecularly Confirmed Bardet-Biedl Syndrome. , 2015, American journal of ophthalmology.
[55] Y. Huang,et al. BBS4 and BBS5 show functional redundancy in the BBSome to regulate the degradative sorting of ciliary sensory receptors , 2015, Scientific Reports.
[56] J. Chiang,et al. The current status of molecular diagnosis of inherited retinal dystrophies , 2015, Current opinion in ophthalmology.
[57] S. E. Barker,et al. Long-term effect of gene therapy on Leber's congenital amaurosis. , 2015, The New England journal of medicine.
[58] A. J. Roman,et al. Improvement in vision: a new goal for treatment of hereditary retinal degenerations , 2015, Expert opinion on orphan drugs.
[59] Anthony G. Robson,et al. Congenital stationary night blindness: An analysis and update of genotype–phenotype correlations and pathogenic mechanisms , 2015, Progress in Retinal and Eye Research.
[60] J. Sahel,et al. Clinical characteristics and current therapies for inherited retinal degenerations. , 2015, Cold Spring Harbor perspectives in medicine.
[61] J. Bennett,et al. The Status of RPE65 Gene Therapy Trials: Safety and Efficacy. , 2015, Cold Spring Harbor perspectives in medicine.
[62] D. Hood,et al. A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and x-linked retinitis pigmentosa. , 2014, Investigative ophthalmology & visual science.
[63] Ken Ogino,et al. PREVALENCE AND SPATIAL DISTRIBUTION OF CYSTOID SPACES IN RETINITIS PIGMENTOSA: Investigation With Spectral Domain Optical Coherence Tomography , 2014, Retina.
[64] R. MacLaren,et al. Evaluation of an Optimized Injection System for Retinal Gene Therapy in Human Patients. , 2014, Human gene therapy methods.
[65] Masayuki Hata,et al. Intraretinal hyperreflective foci on spectral-domain optical coherence tomographic images of patients with retinitis pigmentosa. , 2014, Clinical ophthalmology.
[66] G. La Torre,et al. Dorzolamide Chlorhydrate Versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports , 2014, Ophthalmology and eye diseases.
[67] Jacqueline Pei,et al. Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements , 2013, Human Genetics.
[68] S. Tsang,et al. OUTER RETINAL TUBULATION IN DEGENERATIVE RETINAL DISORDERS , 2013, Retina.
[69] Astrid M L Kappers,et al. Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. , 2013, Ophthalmology.
[70] Makoto Nakamura,et al. Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene , 2013, Proceedings of the National Academy of Sciences.
[71] D. Hood,et al. Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. , 2013, JAMA ophthalmology.
[72] M. Parodi,et al. Spectral Domain Optical Coherence Tomography Findings in Patients with Retinitis Pigmentosa , 2013, Ophthalmic Research.
[73] E. Zrenner,et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies , 2013, European Journal of Human Genetics.
[74] Y. Kim,et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa. , 2013, Investigative ophthalmology & visual science.
[75] Alexander Sumaroka,et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement , 2013, Proceedings of the National Academy of Sciences.
[76] J. Jonas,et al. Prevalence of retinitis pigmentosa in India: the Central India Eye and Medical Study , 2012, Acta ophthalmologica.
[77] Jinghua Hu,et al. The BBSome controls IFT assembly and turnaround in cilia , 2012, Nature Cell Biology.
[78] P. Beales,et al. Bardet–Biedl syndrome , 2012, European Journal of Human Genetics.
[79] A. Moore,et al. Educational paper , 2012, European Journal of Pediatrics.
[80] Kathleen A. Marshall,et al. AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness , 2012, Science Translational Medicine.
[81] J. Vandesompele,et al. Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis , 2012, Genetics in Medicine.
[82] William J Feuer,et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. , 2012, Archives of ophthalmology.
[83] A. J. Roman,et al. Retinal disease course in Usher syndrome 1B due to MYO7A mutations. , 2011, Investigative ophthalmology & visual science.
[84] F. Parmeggiani,et al. Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date , 2011, Current genomics.
[85] S. Ferrari,et al. Retinitis Pigmentosa: Genes and Disease Mechanisms , 2011, Current genomics.
[86] V. Sheffield,et al. Genomics and the eye. , 2011, The New England journal of medicine.
[87] A. Berezovsky,et al. Visual acuity and retinal function in patients with Bardet-Biedl syndrome , 2011, Clinics.
[88] K. Steel,et al. The Usher 1B protein, MYO7A, is required for normal localization and function of the visual retinoid cycle enzyme, RPE65 , 2011, Human molecular genetics.
[89] Fiona Blanco-Kelly,et al. An Update on the Genetics of Usher Syndrome , 2010, Journal of ophthalmology.
[90] T. de Ravel,et al. Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-related Phenotypes , 2010, Human mutation.
[91] Artur V. Cideciyan,et al. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy , 2010, Progress in Retinal and Eye Research.
[92] G. Pazour,et al. Ablation of Whirlin Long Isoform Disrupts the USH2 Protein Complex and Causes Vision and Hearing Loss , 2010, PLoS genetics.
[93] V. Sheffield,et al. Bardet‐Biedl syndrome in Denmark—report of 13 novel sequence variations in six genes , 2010, Human mutation.
[94] E. Rubel,et al. Deafness and retinal degeneration in a novel USH1C knock‐in mouse model , 2010, Developmental neurobiology.
[95] Madeline A. Lancaster,et al. AHI1 is required for outer segment development and is a modifier for retinal degeneration in nephronophthisis , 2010, Nature Genetics.
[96] Jean Bennett,et al. Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[97] J. Sahel,et al. Genotyping microarray for CSNB-associated genes. , 2009, Investigative ophthalmology & visual science.
[98] Kathleen A. Marshall,et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial , 2009, The Lancet.
[99] M. Marra,et al. Massively parallel sequencing: the next big thing in genetic medicine. , 2009, American journal of human genetics.
[100] Kelly Shintani,et al. Review and update: current treatment trends for patients with retinitis pigmentosa. , 2009, Optometry.
[101] A. J. Roman,et al. Disease boundaries in the retina of patients with Usher syndrome caused by MYO7A gene mutations. , 2009, Investigative ophthalmology & visual science.
[102] M. Bitner-Glindzicz,et al. Update on Usher syndrome , 2009, Current opinion in neurology.
[103] M. Bach,et al. ISCEV Standard for full-field clinical electroretinography (2008 update) , 2009, Documenta Ophthalmologica.
[104] Edwin M Stone,et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics , 2008, Proceedings of the National Academy of Sciences.
[105] A. J. Roman,et al. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. , 2008, Human molecular genetics.
[106] Nick Tyler,et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[107] Kathleen A. Marshall,et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.
[108] David S. Williams. Usher syndrome: Animal models, retinal function of Usher proteins, and prospects for gene therapy , 2008, Vision Research.
[109] Dorothy A. Thompson,et al. An assessment of the apex microarray technology in genotyping patients with Leber congenital amaurosis and early-onset severe retinal dystrophy. , 2007, Investigative ophthalmology & visual science.
[110] R. Wilke,et al. Mutation screening of 299 Spanish families with retinal dystrophies by Leber congenital amaurosis genotyping microarray. , 2007, Investigative ophthalmology & visual science.
[111] A. J. Roman,et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. , 2007, Investigative ophthalmology & visual science.
[112] Christina Zeitz,et al. Night blindness–associated mutations in the ligand‐binding, cysteine‐rich, and intracellular domains of the metabotropic glutamate receptor 6 abolish protein trafficking , 2007, Human mutation.
[113] D. S. Williams,et al. Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B , 2007, Gene Therapy.
[114] R. Lewis,et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus , 2006, Nature Genetics.
[115] J. Cruysberg,et al. Microarray-based mutation detection and phenotypic characterization of patients with Leber congenital amaurosis. , 2006, Investigative ophthalmology & visual science.
[116] T. Aleman,et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[117] Steve D. M. Brown,et al. Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population , 2005, Human Genetics.
[118] Edward N. Pugh,et al. From candelas to photoisomerizations in the mouse eye by rhodopsin bleaching in situ and the light-rearing dependence of the major components of the mouse ERG , 2004, Vision Research.
[119] R. Allikmets. Leber congenital amaurosis: a genetic paradigm , 2004, Ophthalmic genetics.
[120] David S. Williams,et al. Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[121] B. Lorenz,et al. Genotyping microarray (disease chip) for Leber congenital amaurosis: detection of modifier alleles. , 2003, Investigative ophthalmology & visual science.
[122] David S. Williams,et al. Actin-based motor properties of native myosin VIIa. , 2002, Journal of cell science.
[123] S. Jacobson,et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa , 2000, Nature Genetics.
[124] G. Fishman,et al. Patterns of visual field progression in patients with retinitis pigmentosa. , 1998, Ophthalmology.
[125] A. Milam,et al. Histopathology of the human retina in retinitis pigmentosa. , 1998, Progress in retinal and eye research.
[126] G. Hitman,et al. Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families. , 1997, Journal of medical genetics.
[127] Steve D. M. Brown,et al. Defective myosin VIIA gene responsible for Usher syndrome type IB , 1995, Nature.
[128] A. Hendrickson,et al. Human photoreceptor topography , 1990, The Journal of comparative neurology.
[129] S Berman,et al. Retinal damage by light in rats. , 1966, Investigative ophthalmology.
[130] L. Riggs. Electroretinography in cases of night blindness. , 1954, American journal of ophthalmology.
[131] G. Schubert,et al. Beitrag zur Analyse des menschlichen Elektroretinogramms , 1952 .
[132] F. Cremers,et al. Identification and Analysis of Genes Associated with Inherited Retinal Diseases. , 2019, Methods in molecular biology.
[133] A. Cideciyan,et al. Leber Congenital Amaurosis: Genotypes and Retinal Structure Phenotypes. , 2016, Advances in experimental medicine and biology.
[134] Donald C Hood,et al. The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. , 2011, Investigative ophthalmology & visual science.
[135] J. Heckenlively,et al. Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy , 2004, Nature Genetics.
[136] R. A. Pagon,et al. Retinitis pigmentosa. , 1988, Survey of ophthalmology.